Multiple Sclerosis, Relapsing-Remitting: all 615 studies
Page 1 of 7. Open to participants first (80), then studies with results posted, then the rest; newest registration first within each.
- A Study to Evaluate the Preliminary Efficacy and Safety of Terfenadine in Patients With Relapsing-Remitting Multiple SclerosisRecruitingNCT07827716Phase 2
- Non-interventional Study of Subcutaneous Ocrelizumab in Persons With Relapsing-Remitting Multiple SclerosisRecruitingNCT07827586
- A Study of Rocbrutinib in PRL-Positive Relapsing-Remitting Multiple SclerosisRecruitingNCT07776743Phase 2
- Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.RecruitingNCT07758270
- Sociocognitive Intervention and Rehabilitation Program in Multiple SclerosisNot yet recruitingNCT07734675Not applicable
- Effects of Powered Hip Flexion Device in Persons With Multiple SclerosisNot yet recruitingNCT07724093Not applicable
- PRIMUS : Real World Usage for Real World Evidence of CDSS Use in Multiple SclerosisNot yet recruitingNCT07647952Not applicable
- Effects of Low-Load Blood Flow Restriction Exercise on Rectus Femoris Muscle Morphology in Individuals With Relapsing-Remitting Multiple SclerosisNot yet recruitingNCT07645937Not applicable
- Acute Intermittent Hypoxia Combined With Gait Training in Multiple SclerosisNot yet recruitingNCT07631923Not applicable
- Healthy Eating and Active Living for People Living With Multiple Sclerosis (HEAL MS): A Lifestyle Program for People With Multiple SclerosisNot yet recruitingNCT07589062Not applicable
- Multicenter Prospective Study Analyzing the Occurrence of Multiple Sclerosis Relapses Without Radiological Evidence: Myth or Reality?Not yet recruitingNCT07545889Not applicable
- The HIt HArd and hiT Early in Multiple Sclerosis TrialRecruitingNCT07517185Phase 2
- A Study to Evaluate Pharmacokinetics, Safety, Tolerability, Immunogenicity and Pharmacodynamic Effects of Subcutaneous Ocrelizumab Administration in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS)Not yet recruitingNCT07503340Phase 2
- Cognitive Performance, Sleep Disturbances and Fatigue in Multiple SclerosisRecruitingNCT07426991
- Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot StudyRecruitingNCT07376772Not applicable
- Myrosinase Bioactivated Gglucoraphanin for the Treatment of Neurodegenerative Diseases (GRA-MYR-ND)RecruitingNCT07360977Not applicable
- Home Based Functional Balance Intervention for Multiple SclerosisRecruitingNCT07355387Not applicable
- A Study of the Efficacy and Safety of BCD-281 in Patients With Relapsing-Remitting Multiple SclerosisRecruitingNCT07321093Phase 3
- Indole-3-PROpionic Acid Clinical Trials - Multiple SclerosisRecruitingNCT07318129Not applicable
- Monthly Monitoring of Plasma NfL in Treated Relapsing-remitting Multiple Sclerosis to Detect Persistent Infraclinical Disease ActivityRecruitingNCT07292480Not applicable
- Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis: A Trans-regional Digital Health Effort Unlocking the Potential of Artificial Intelligence and Data Science in Health CareNot yet recruitingNCT07280871
- A Multicenter Clinical Trial Evaluating the Efficacy and Safety of Taurine as an Adjunctive Therapy in Multiple SclerosisNot yet recruitingNCT07263607Phase 2
- Combined Motor Imagery and Vestibular Rehab for MSRecruitingNCT07230015Not applicable
- Ublituximab (Briumvi) for Early Forms of Relapsing Multiple SclerosisRecruitingNCT07225361Phase 4
- A Study of Remibrutinib Using MR Imaging in Relapsing or Progressive MSNot yet recruitingNCT07222956Phase 2
- "Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MSRecruitingNCT07222618
- Sexual Dysfunction in Women With Multiple Sclerosis (MS)RecruitingNCT07193823
- A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple SclerosisRecruitingNCT07189325Phase 3
- Administration of Fingolimod in Greek Patients With Multiple Sclerosis.Not yet recruitingNCT06949956
- Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple SclerosisRecruitingNCT06919900Not applicable
- Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple SclerosisRecruitingNCT06864936Not applicable
- The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot StudyRecruitingNCT06796504Not applicable
- ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMSRecruitingNCT06733922Phase 4
- Multiple Sclerosis and the Effects of Ketogenic Diet TherapyRecruitingNCT06715436Not applicable
- Disease Modifying Therapies Withdrawal in Inactive Relapsing-remitting Multiple Sclerosis Patients Aged 55 and Over (TWINS : Therapies Withdrawal IN Relapsing Multiple Sclerosis)Not yet recruitingNCT06663189Phase 3
- Rituximab and Ocrelizumab in Serum With Multiple SclerosisRecruitingNCT06663111
- Study to Investigate Vagus Nerve Stimulation Paired With Motor Task for Remyelination and Functional RecoveryEnrolling by invitationNCT06641271Not applicable
- Effects of Ublituximab on Motor Functions in Multiple SclerosisRecruitingNCT06629428Early Phase 1
- Understanding the 'Durable Effect' Concept of B-cell Modulating TherapiesRecruitingNCT06586177
- Fatigue Alleviation Through Neuromodulating Therapy in Multiple SclerosisRecruitingNCT06569550Not applicable
- Multiple Sclerosis Treatment With Autologous Hematopoietic Stem Cell Transplantation in the NetherlandsRecruitingNCT06567197
- Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis (Switzerland)RecruitingNCT06526364
- Development of Camera Based Gait Quality Measure for Persons With Multiple SclerosisRecruitingNCT06516458
- Effects of Ocrelizumab Treatment on Immune Cells in Lymph Nodes in Multiple SclerosisEnrolling by invitationNCT06495593Phase 4
- Productive Value of Sonographic Measurement of Optic Nerve in Transitional MultipleNot yet recruitingNCT06435962
- Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple SclerosisRecruitingNCT06408259Phase 3
- Effects of Acute Intermittent Hypoxia on Neuroplasticity in MSRecruitingNCT06390930Not applicable
- Light Stimulation to Improve Visual Function After Optic Neuritis in Persons with Multiple SclerosisRecruitingNCT06389968Not applicable
- Ifenprodil as a ReMyelinating repurpOsed Drug in Multiple SclerosisNot yet recruitingNCT06330077Phase 2
- the EXPOSITION StudyNot yet recruitingNCT06325358
- Targeting Subclinical Motor and Cognitive Impairment in Patients With Early Onset Multiple SclerosisRecruitingNCT06303024Not applicable
- Intermittent Hypoxia in Persons With Multiple SclerosisRecruitingNCT06276634Not applicable
- Identifying Immune Biomarkers of Disease and Disease Control in Autoimmune Neurological Disease Using Autologous Haematopoietic Stem Cell TransplantationRecruitingNCT06195800
- Comparative Study of High-Efficacy Disease Modifying Treatment of Relapsing Multiple SclerosisRecruitingNCT06159712Not applicable
- Impact of the Cionic Neural Sleeve on Mobility in Multiple SclerosisRecruitingNCT05964829Not applicable
- Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current StimulationRecruitingNCT05958381Not applicable
- Effects of a Combined Supplementation of Conjugated Linoleic Acid (CLA) and Probiotics (Vivomixx®) as add-on to a First-line Immunotherapy in Relapsing-remitting Multiple SclerosisRecruitingNCT05920018Not applicable
- A Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients With Relapsing-remitting Multiple SclerosisRecruitingNCT05906992Phase 3
- Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MSRecruitingNCT05834855Phase 3
- RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis.RecruitingNCT05758831Phase 3
- Physical Activity, Sedentary Behaviour and Cardiometabolic Health in Multiple SclerosisRecruitingNCT05752630
- Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple SclerosisEnrolling by invitationNCT05706220
- The Relationships Between Personal Identity, Autobiographical Memory and Future Thinking in People With Multiple SclerosisRecruitingNCT05648292
- Multiparametric Assessment to Investigate Prognostic Factors for Disease Evolution a nd Evolutionary Patterns of Cognitive Status in RRMSRecruitingNCT05510817Not applicable
- Exercise Effects in Multiple SclerosisRecruitingNCT05496881Not applicable
- Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair TherapyRecruitingNCT05359653Phase 1/2
- Implementation of a Novel Functional Eye-Tracking Biomarker for Multiple SclerosisRecruitingNCT05277740
- MS-ResearchBiomarkerSRecruitingNCT05204459
- Imaging the Interplay Between Axonal Damage and Repair in Multiple SclerosisRecruitingNCT05177523
- An Examination of Cognitive Fatigue Using Functional NeuroimagingRecruitingNCT04885894
- Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple SclerosisNot yet recruitingNCT04768777Not applicable
- Investigation of Subclinical Markers of Multiple SclerosisRecruitingNCT04604041
- Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple SclerosisRecruitingNCT04480853Phase 4
- Investigating the Effect of Ocrelizumab in African Americans and Caucasians With Relapsing Multiple SclerosisRecruitingNCT04458688
- Patient Experiences of Multiple Sclerosis (PExMS)Not yet recruitingNCT04236544Not applicable
- Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)RecruitingNCT04047628Phase 3
- TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple SclerosisRecruitingNCT03910738Phase 2
- SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple SclerosisRecruitingNCT03783416Phase 1
- Retinal Neuro-vascular Coupling in Patients With Multiple SclerosisRecruitingNCT03401879Not applicable
- Tolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERVIT-MS)RecruitingNCT02903537Phase 1
- Peptide-coupled Red Blood Cells for the Treatment of Multiple SclerosisCompletedNCT06430671Phase 1Results posted
- A Study to Evaluate Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of Natalizumab (BG00002) Administered Subcutaneously to Japanese Participants With Relapsing-Remitting Multiple SclerosisTerminatedNCT05265728Phase 3Results posted
- A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS)Active, not recruitingNCT05123703Phase 3Results posted
- Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying TherapyCompletedNCT05028634Phase 3Results posted
- Effectiveness of Cladribine Tablets in Participants With Highly-active Relapsing Multiple Sclerosis (CAMELOT-MS)CompletedNCT04997148Results posted
- Effects of Chiropractic Care on Cytokine Levels in Multiple SclerosisCompletedNCT04972929Not applicableResults posted
- Addition of Belimumab to B-cell Depletion in Relapsing-remitting Multiple SclerosisTerminatedNCT04767698Phase 2Results posted
- Assessment of ANK-700 in Patients With Relapsing Remitting Multiple SclerosisCompletedNCT04602390Phase 1Results posted
- Comparative Bioavailability of BAFIERTAM™ (Monomethyl Fumarate) and Tecfidera® (Dimethyl Fumarate) in Healthy SubjectsCompletedNCT04570670Phase 1Results posted
- A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)Active, not recruitingNCT04544436Phase 3Results posted
- Effects of Ocrelizumab on B-cell Tolerance Defect in Relapsing Multiple SclerosisCompletedNCT04261790Phase 4Results posted
- A Study to Asses Efficacy, Safety and Tolerability of Monthly Long-acting IM Injection of GA Depot in Subjects With RMSCompletedNCT04121221Phase 3Results posted
- Efficacy and Safety of the Biosimilar Natalizumab PB006 in Comparison to Tysabri®CompletedNCT04115488Phase 3Results posted
- Study of Evobrutinib in Participants With RMSTerminatedNCT04032171Phase 3Results posted
- Study of Evobrutinib in Participants With Relapsing Multiple Sclerosis (RMS)TerminatedNCT04032158Phase 3Results posted
- Cladribine Tablets: Collaborative Study to Evaluate Impact On Central Nervous System Biomarkers in Multiple SclerosisCompletedNCT03963375Phase 4Results posted
- Study to Evaluate the Efficacy and Safety of Dimethyl Fumarate (Tecfidera) and Peginterferon Beta-1a (Plegridy) for the Treatment of Relapsing-Remitting Multiple Sclerosis in Pediatric ParticipantsTerminatedNCT03870763Phase 3Results posted
- MRI Trial to exPlore the efficAcy and Safety of IMU-838 in Relapsing Remitting Multiple Sclerosis (EMPhASIS)Active, not recruitingNCT03846219Phase 2Results posted
- A Study to Evaluate Efficacy, Safety, and Tolerability of EID of Natalizumab (BG00002) in Participants With RRMS Switching From Treatment With Natalizumab SID in Relation to Continued SID Treatment- Followed by Extension Study Comprising SC and IV Natalizumab AdministrationCompletedNCT03689972Phase 3Results posted
- Fecal Microbiota Transplantation (FMT) of FMP30 in Relapsing-Remitting Multiple SclerosisTerminatedNCT03594487Phase 1Results posted